Marito Araki

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

A higher JAK2V617F allele burden may be a risk factor for hemorrhagic events in younger patients with polycythemia vera.

A higher JAK2V617F allele burden may be a risk factor for hemorrhagic events in younger patients with polycythemia vera.

Journal: Hematology (Amsterdam, Netherlands)

Published: November 15, 2024

Differential clearance rate of proteins encoded on a self-amplifying mRNA COVID-19 vaccine in muscle and lymph nodes.

Differential clearance rate of proteins encoded on a self-amplifying mRNA COVID-19 vaccine in muscle and lymph nodes.

Journal: Biochemistry and biophysics reports

Published: October 03, 2024

Short-term outcomes of delta-shaped anastomosis versus functional end-to-end anastomosis using linear staplers for colon cancer.

Short-term outcomes of delta-shaped anastomosis versus functional end-to-end anastomosis using linear staplers for colon cancer.

Journal: Techniques in coloproctology

Published: May 18, 2024

Involvement of CREB3L1 in erythropoiesis induced by JAK2 exon 12 mutation.

Involvement of CREB3L1 in erythropoiesis induced by JAK2 exon 12 mutation.

Journal: Experimental hematology

Published: November 14, 2023

Impact of non-driver gene mutations on thrombo-haemorrhagic events in ET patients.

Impact of non-driver gene mutations on thrombo-haemorrhagic events in ET patients.

Journal: British journal of haematology

Published: August 21, 2023

MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in Japan.

MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in Japan.

Journal: Hematology (Amsterdam, Netherlands)

Published: June 28, 2023

Activated mesenchymal stem/stromal cells promote myeloid cell differentiation via CCL2/CCR2 signaling.

Activated mesenchymal stem/stromal cells promote myeloid cell differentiation via CCL2/CCR2 signaling.

Journal: Stem cell reports

Published: May 16, 2023

Reevaluation of cardiovascular risk factors for thrombotic events in 580 Japanese patients with essential thrombocythemia.

Reevaluation of cardiovascular risk factors for thrombotic events in 580 Japanese patients with essential thrombocythemia.

Journal: Journal of thrombosis and thrombolysis

Published: December 03, 2022

Causes of Thrombocytosis: A Single-center Retrospective Study of 1,202 Patients.

Causes of Thrombocytosis: A Single-center Retrospective Study of 1,202 Patients.

Journal: Internal medicine (Tokyo, Japan)

Published: November 17, 2022

Phase 1 Clinical Trial of PPMX-T003, a Novel Human Monoclonal Antibody Specific for Transferrin Receptor 1, to Evaluate Its Safety, Pharmacokinetics, and Pharmacodynamics.

Phase 1 Clinical Trial of PPMX-T003, a Novel Human Monoclonal Antibody Specific for Transferrin Receptor 1, to Evaluate Its Safety, Pharmacokinetics, and Pharmacodynamics.

Journal: Clinical pharmacology in drug development

Published: October 17, 2022

Establishment of isogenic induced pluripotent stem cells with or without pathogenic mutation for understanding the pathogenesis of myeloproliferative neoplasms.

Establishment of isogenic induced pluripotent stem cells with or without pathogenic mutation for understanding the pathogenesis of myeloproliferative neoplasms.

Journal: Experimental hematology

Published: August 23, 2022

Non-driver gene mutation analysis in a large cohort of polycythemia vera and essential thrombocythemia.

Non-driver gene mutation analysis in a large cohort of polycythemia vera and essential thrombocythemia.

Journal: European journal of haematology

Published: August 22, 2022

Showing 1-12 of 60

Last Updated: 09/26/2026